We are live on ! Find out more
SVNT

SAVIENT PHARMACEUTICALS INC
SVNT

Delisted

SVNT was delisted on the 16th of October, 2013.

Back to rankings

7 hedge funds and large institutions have $5K invested in SAVIENT PHARMACEUTICALS INC in 2013 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% less funds holding

Funds holding: 41 → 7 (-34)

95% less call options, than puts

Call options by funds: $3K | Put options by funds: $62K

97% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 34

100% less capital invested

Capital invested by funds: $13M → $5K (-$13M)

Holders
7
Holders Change
-34
Holders Change %
-82.93%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
–
Closed
34
Calls
$3K
Puts
$62K
Net Calls
-$59K
Net Calls Change
-$40K

Top Buyers

Rank Fund Capital Flow
1
Group One Trading
Group One Trading
Illinois
+$52.4K

Top Sellers

Rank Fund Capital Flow
1
PAI
Palo Alto Investors
California
-$5.46M
2
Franklin Resources
Franklin Resources
California
-$2.31M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$2.08M
4
BIT
BlackRock Institutional Trust
California
-$1.4M
5
Wellington Management Group
Wellington Management Group
Massachusetts
-$450K
Name Holding Trade Value Shares
Change 		Change in
Stake
Group One Trading
1
Group One Trading
Illinois
$2K +$52.4K +103,410 +295%
FHC
2
First Heartland Consultants
Missouri
$1K – – –
PSC
3
Prentiss Smith & Co
Vermont
$1K – – –
WS
4
Wedbush Securities
California
$1K – – –
PAI
5
Palo Alto Investors
California
– -$5.46M -8,752,981 Closed
Franklin Resources
6
Franklin Resources
California
– -$2.31M -3,693,510 Closed
Vanguard Group
7
Vanguard Group
Pennsylvania
– -$2.08M -3,337,281 Closed
BIT
8
BlackRock Institutional Trust
California
– -$1.4M -2,245,944 Closed
Wellington Management Group
9
Wellington Management Group
Massachusetts
– -$450K -720,971 Closed
Geode Capital Management
10
Geode Capital Management
Massachusetts
– -$193K -308,749 Closed
Millennium Management
11
Millennium Management
New York
– -$192K -308,226 Closed
Morgan Stanley
12
Morgan Stanley
New York
– -$137K -219,110 Closed
BCM
13
Bridgeway Capital Management
Texas
– -$117K -186,748 Closed
Northern Trust
14
Northern Trust
Illinois
– -$105K -168,883 Closed
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
– -$75K -120,673 Closed
VKH
16
Virtu KCG Holdings
New York
– -$73K -117,567 Closed
Nomura Holdings
17
Nomura Holdings
Japan
– -$52K -81,300 Closed
U
18
UBS
Switzerland
– -$49K -78,113 Closed
Citigroup
19
Citigroup
New York
– -$40K -64,415 Closed
Deutsche Bank
20
Deutsche Bank
Germany
– -$31K -50,001 Closed
State Street
21
State Street
Massachusetts
– -$31K -49,132 Closed
Citadel Advisors
22
Citadel Advisors
Florida
– -$20K -31,407 Closed
Creative Planning
23
Creative Planning
Kansas
– -$19K -30,500 Closed
GC
24
Guggenheim Capital
Illinois
– -$18K -28,310 Closed
Goldman Sachs
25
Goldman Sachs
New York
– -$13K -21,104 Closed
1
2

SVNT Hedge Fund Activity: Q4 2013 in Review

7 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in SAVIENT PHARMACEUTICALS INC (SVNT) for Q4 2013, worth a combined $5K — down 100% from $13M a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of SVNT and 1 opened new positions — a net loss of 33 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was Group One Trading, adding an estimated $52.4K. The largest seller was Palo Alto Investors, exiting entirely with an estimated $5.46M sold.

  • 7 institutional investors held SAVIENT PHARMACEUTICALS INC (SVNT) as of Q4 2013, down from 41 in Q3 2013.
  • Funds reported $5K of SAVIENT PHARMACEUTICALS INC stock for Q4 2013, down 100% quarter-over-quarter.
  • 1 fund opened new SAVIENT PHARMACEUTICALS INC positions in Q4 2013 and 34 closed out, a net change of -33 holders.
  • The largest SAVIENT PHARMACEUTICALS INC buyer in Q4 2013 was Group One Trading, an estimated $52.4K added.
  • The largest SAVIENT PHARMACEUTICALS INC seller in Q4 2013 was Palo Alto Investors, an estimated $5.46M sold.

Based on aggregated 13F filings for Q4 2013.